These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 23403334)

  • 21. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus.
    Winau L; Hinojar Baydes R; Braner A; Drott U; Burkhardt H; Sangle S; D'Cruz DP; Carr-White G; Marber M; Schnoes K; Arendt C; Klingel K; Vogl TJ; Zeiher AM; Nagel E; Puntmann VO
    Ann Rheum Dis; 2018 Nov; 77(11):1590-1598. PubMed ID: 30077990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of community-acquired pneumonia on myocardial injury in systemic lupus erythematosus: Insights from cardiac magnetic resonance.
    Cui B; Pu H; Liu J; He W; Zhou Y; Xiaoyue Zhou ; Lin H; Peng L
    Lupus; 2022 Sep; 31(10):1263-1268. PubMed ID: 35667652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
    Takase B; Nagata M
    Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of left atrial function by speckle tracking echocardiography in patients with systemic lupus erythematosus.
    Dai M; Li KL; Qian DJ; Lu J; Zou YH; Cao YX; Yang ZY; Wang RX
    Lupus; 2016 Apr; 25(5):496-504. PubMed ID: 26657736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
    Iles L; Pfluger H; Phrommintikul A; Cherayath J; Aksit P; Gupta SN; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2008 Nov; 52(19):1574-80. PubMed ID: 19007595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.
    Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cardiac autonomic functions in patients with systemic lupus erythematosus.
    Yorgun H; Canpolat U; Aytemir K; Ateş AH; Kaya EB; Akdoğan A; Sunman H; Gökçay Canpolat A; Çalgüneri M; Kabakçi G; Tokgözoğlu L; Oto A
    Lupus; 2012 Apr; 21(4):373-9. PubMed ID: 22009461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.
    Smith GC; Kinali M; Prasad SK; Bonne G; Muntoni F; Pennell DJ; Nihoyannopoulos P
    J Cardiovasc Magn Reson; 2006; 8(5):723-30. PubMed ID: 16891232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
    Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance.
    Keenan NG; Mason JC; Maceira A; Assomull R; O'Hanlon R; Chan C; Roughton M; Andrews J; Gatehouse PD; Firmin DN; Pennell DJ
    Arthritis Rheum; 2009 Nov; 60(11):3501-9. PubMed ID: 19877040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late enhancement detected by cardiac magnetic resonance imaging in acute myocarditis mimicking acute myocardial infarction: location patterns and lack of correlation with systolic function.
    Camastra GS; Cacciotti L; Marconi F; Sbarbati S; Pironi B; Ansalone G
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1029-33. PubMed ID: 18163015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
    Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
    Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular magnetic resonance evaluation of paediatric patients with systemic lupus erythematosus and cardiac symptoms.
    Mavrogeni S; Smerla R; Grigoriadou G; Servos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Spiliotis G; Kolovou G; Papadopoulos G
    Lupus; 2016 Mar; 25(3):289-95. PubMed ID: 26453663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.
    Messroghli DR; Nordmeyer S; Dietrich T; Dirsch O; Kaschina E; Savvatis K; O h-Ici D; Klein C; Berger F; Kuehne T
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):636-40. PubMed ID: 21917782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
    Karamitsos TD; Piechnik SK; Banypersad SM; Fontana M; Ntusi NB; Ferreira VM; Whelan CJ; Myerson SG; Robson MD; Hawkins PN; Neubauer S; Moon JC
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):488-97. PubMed ID: 23498672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D; Shah DJ; Farah GM; Di Luzio S; Parker M; Johnson MR; Cotts WG; Klocke FJ; Bonow RO; Judd RM; Gheorghiade M; Kim RJ
    Circulation; 2003 Oct; 108(16):1945-53. PubMed ID: 14557364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.